SCHEMBL14725112

SCHEMBL14725112

COC(=O)C(F)CNCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.51
MAPT P10636 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
ANPEP P15144 1/20 0.50
TSHR P16473 1/20 0.49
ATM Q13315 4/20 0.48
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.46
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
ALDH1A1 P00352 2/20 0.44
BCHE P06276 1/20 0.43
CA12 O43570 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14611828 1.00 SMN1; SMN2 (0.51) SMN1; SMN2MAPTL3MBTL1ANPEPTSHR
SCHEMBL13070592 0.84 ANPEP (0.54) SMN1; SMN2MAPTL3MBTL1ANPEPATM
SCHEMBL29888629 0.84 ANPEP (0.54) SMN1; SMN2MAPTL3MBTL1ANPEPATM
SCHEMBL5761505 0.84 ANPEP (0.54) SMN1; SMN2MAPTL3MBTL1ANPEPATM
SCHEMBL1627443 0.83 SMN1; SMN2 (0.54) SMN1; SMN2MAPTL3MBTL1ANPEPATM
SCHEMBL13088679 0.83 ANPEP (0.60) SMN1; SMN2MAPTANPEPTSHRATM
Hydrochloric Acid SCHEMBL5761503 0.83 ANPEP (0.53) SMN1; SMN2MAPTL3MBTL1ANPEPATM
SCHEMBL23102214 0.82 MAPT (0.55) SMN1; SMN2MAPTL3MBTL1ANPEPATM
SCHEMBL12548382 0.82 MAPT (0.55) SMN1; SMN2MAPTL3MBTL1ANPEPATM
SCHEMBL1161723 0.82 MAPT (0.55) SMN1; SMN2MAPTL3MBTL1ANPEPATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765789-B1 N-(1-(1-BENZYL-4-PHENYL-1H-IMIDAZOL-2-YL)-2,2-DIMETHYLPROPYL)BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPINDLE PROTEIN (KSP) INHIBITORS FOR THE TREATMENT OF CANCER NOVARTIS AG (CH) 2013-02-27 EP disclosed